19-1386644-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM2PP5_ModerateBP4
The NM_024407.5(NDUFS7):c.17-1167C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_024407.5 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NDUFS7 | NM_024407.5 | c.17-1167C>G | intron_variant | Intron 1 of 7 | ENST00000233627.14 | NP_077718.3 | ||
NDUFS7 | NM_001363602.2 | c.17-1167C>G | intron_variant | Intron 1 of 7 | NP_001350531.1 | |||
NDUFS7 | XM_017026768.3 | c.17-1167C>G | intron_variant | Intron 1 of 3 | XP_016882257.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 0
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Leigh syndrome Pathogenic:1
Variant summary: NDUFS7 c.17-1167C>G is located at a position not widely known to affect splicing. Several computational tools predict a significant impact on normal splicing: Four predict the variant strengthens a cryptic 5' splicing donor site. However, these predictions have yet to be confirmed by functional studies. The variant was absent in 31372 control chromosomes. c.17-1167C>G has been reported in the literature in two homozygous siblings affected with Leigh Syndrome (Lebon_2007). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in a defect in mitochondrial complex I assembly (Lebon_2007) and using cell lines derived from these patients, Lebon_2015 showed that the variant had 35% NADH ubiquinone reductase activity compared to wildtype. The following publications have been ascertained in the context of this evaluation (PMID: 17604671, 26024641). ClinVar contains an entry for this variant (Variation ID: 7683). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Mitochondrial complex 1 deficiency, nuclear type 3 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at